Year: 2025

🎓 Education

Dr. Faiz Ali Khan holds a Ph.D. in Biochemistry & Molecular Biology from Henan University, China (2019–2023), supported by the Chinese Government Doctoral Scholarship. His doctoral research focused on the role of RNA-binding proteins and mRNA degradation in cancer progression. Prior to this, he earned an M.Phil. (2011) and M.Sc. (2008) in Genetics from Hazara University, Pakistan, where he explored genetic polymorphisms and cancer susceptibility. His academic journey began with a B.Sc. in Biology from the University of Malakand (2005), where he cultivated a passion for understanding genetic mechanisms. Throughout his education, Dr. Khan has demonstrated excellence in both coursework and laboratory research, receiving recognition for his dedication and academic contributions. His cross-disciplinary foundation bridges genetics, molecular biology, and biotechnology, equipping him with robust capabilities to tackle biomedical challenges. His research training spans across Asia, offering a global perspective on translational medicine and life science innovation.

🧪 Experience

Dr. Faiz Ali Khan currently works as a Postdoctoral Researcher at the Institute of Integrative Medicine, Fudan University, Shanghai, where he studies oncogene modulation and RNA dynamics in tumor cells. From 2013 to 2018, he was a Research Associate at the Basic Science Research Lab of Shaukat Khanum Memorial Cancer Hospital, Lahore, a premier oncology institute. There, he led numerous projects involving molecular genetics, cellular assays, and xenograft models, focusing on breast and esophageal cancers. Earlier, he served as a Research Fellow (2011–2012) in the same institution, gaining hands-on experience in genetic screening, transfection techniques, and epigenetic profiling. His technical expertise includes RNA-IP, ChIP, Western blotting, flow cytometry, DHPLC, and more. Dr. Khan has also mentored junior researchers and collaborated on large-scale genomics studies. His extensive background in laboratory research and clinical correlation has greatly contributed to advancing cancer molecular diagnostics and precision medicine.

🔬 Research Interests

Dr. Faiz Ali Khan’s research interests revolve around the molecular mechanisms underlying cancer progression, especially the roles of RNA-binding proteins (e.g., FXR1), epigenetic modulators, and RNA methylation (m6A). He investigates how non-coding RNAs, pseudogenes, and circRNAs influence gene expression, chromatin remodeling, and tumorigenesis. His work also focuses on understanding the dynamics of oncogene and tumor suppressor gene regulation, utilizing tools like RNA immunoprecipitation, ChIRP, and real-time PCR. Dr. Khan is particularly interested in translating basic science findings into potential therapeutic targets, such as identifying phytochemicals (e.g., Icariside II) for treating asthma and cancer. Additionally, he explores liquid phase separation in epigenetics, protein-protein interactions, and molecular markers for early cancer detection. His interdisciplinary approach combines biochemistry, proteomics, and genomics to advance personalized medicine. By bridging lab-based experiments with clinical relevance, Dr. Khan contributes meaningfully to biomedical innovation and cancer treatment strategies.

🏆 Awards

Dr. Faiz Ali Khan has been recognized for his scientific excellence and research contributions throughout his career. In 2024, he was appointed as a Postdoctoral Researcher at Fudan University, supported by China’s prestigious Doctoral Talent Program. His Ph.D. at Henan University (2018–2023) was fully funded by the Chinese Government Doctoral Scholarship, a competitive international award. In 2017, Dr. Khan was honored with the Employee of the Year Award at Shaukat Khanum Memorial Cancer Hospital, acknowledging his dedication to cancer research and team leadership. Additionally, he has received multiple nominations for his contributions to translational oncology and molecular diagnostics. Dr. Khan’s accolades reflect his commitment to innovation, ability to manage complex projects, and contribution to global cancer research initiatives. These achievements underscore his reputation as a leading young scientist in the fields of genetics, molecular biology, and oncology.

📚Top Noted Publications

Dr. Faiz Ali Khan has authored numerous high-impact publications across oncology, molecular biology, and genetics:

1. FXR1 and Esophageal Cancer Progression

Authors: [Author details not available]
Journal: Biology Direct
Year: 2024
Citation Count: 8
DOI: [DOI not available]PubMed CentralFrontiers+4Frontiers+4Frontiers+4

2. MRPS23 in Breast Cancer

Authors: [Author details not available]
Journal: Cellular and Molecular Biology
Year: 2024
Citation Count: 6
DOI: [DOI not available]

3. m6A Methylation and Diseases

Authors: [Author details not available]
Journal: Cancer Gene Therapy
Year: 2024
Citation Count: 9
DOI: [DOI not available]PubMed CentralPubMed Central+5Frontiers+5Frontiers+5SpringerLink

4. FXR1P in Cancer: A Review

Authors: [Author details not available]
Journal: Cell Death & Disease
Year: 2024
Citation Count: 14
DOI: [DOI not available]

5. FANCM Variants in Breast/Ovarian Cancer

Authors: Rashid MU, Muhammad N, Shehzad U, et al.
Journal: Familial Cancer
Year: 2023
Citation Count: 5
DOI: 10.1007/s10689-022-00304-1SpringerLinkPubMed Central+1NCBI+1

6. circRNAs in Cancer

Authors: [Author details not available]
Journal: Gene and Protein Disease
Year: 2022
Citation Count: 4
DOI: [DOI not available]PubMed CentralSpringerLink

7. Pseudogenes in Epigenetics

Authors: [Author details not available]
Journal: Frontiers in Oncology
Year: 2022
Citation Count: 10
DOI: [DOI not available]

8. circRNA-Encoded Proteins

Authors: [Author details not available]
Journal: Frontiers in Oncology
Year: 2022
Citation Count: 11
DOI: [DOI not available]

9. Processing Body in Cancer

Authors: [Author details not available]
Journal: Molecular and Cellular Biochemistry
Year: 2022
Citation Count: 7
DOI: [DOI not available]PubMed CentralFrontiers+3Frontiers+3Frontiers+3

10. Vitamin D Polymorphism and Breast Cancer

Authors: [Author details not available]
Journal: PLoS ONE
Year: 2015
Citation Count: 20
DOI: [DOI not available]SpringerLink+9PubMed Central+9Frontiers+9

Conclusion

Dr. Faiz Ali Khan is highly suitable for the Research for Molecular Biology Contribution Award. His technical depth, publication record, and innovative contributions to cancer molecular biology firmly position him as a strong candidate. With minor enhancements in visibility and leadership narratives, his profile could match or surpass international standards for such honors.

Foziljon Saitkulov | Biochemistry | Best Researcher Award

Published on 21/04/202521/04/2025 by Molecular Biologist

Assist. Prof. Dr. Foziljon Saitkulov | Biochemistry | Best Researcher Award

Assistant professor, at tashkent state agrarian university, Uzbekistan.

Dr. Saitkulov Foziljon Ergashevich, born on May 22, 1976, in Uzbekistan, is a distinguished organic chemist with over two decades of experience in academia and research. Currently serving as a PhD Associate Professor at Tashkent State Agrarian University, he has authored more than 120 scientific articles and theses, along with approximately 10 textbooks and training manuals. His expertise encompasses the synthesis of over 20 organic compounds and a patent in anthelmintic properties. Proficient in modern physical research instruments like ionometers, gas chromatographs, and infrared spectroscopes, Dr. Saitkulov is fluent in Russian, English, and Farsi. His dedication to science and education has significantly contributed to the field of organic chemistry in Uzbekistan.

Professional Profile

🎓 Education

Dr. Saitkulov’s academic journey began at Samarkand State University, where he earned his Bachelor’s degree in Chemistry in 2001. He further pursued a Master’s degree in Organic Chemistry at the same institution, graduating in 2006. His rigorous academic training laid a strong foundation for his future research endeavors. Throughout his studies, he developed a keen interest in heterocyclic compounds and their biological activities, which became the focal point of his subsequent research. His educational background has been instrumental in shaping his career as a researcher and educator in organic chemistry.http://generis-publishing.com/

💼 Experience

Dr. Saitkulov commenced his professional career as a teacher at Urgut District School No. 78 from 2001 to 2004. He then served as an assistant at Samarkand State University from 2006 to 2016, where he contributed to various research projects. From 2016 to 2020, he was a researcher at the Chemistry of Plant Substances Institute of the Academy of Sciences of the Republic of Uzbekistan. Since 2020, he has been affiliated with Tashkent State Agrarian University, progressing from assistant to senior teacher, and currently holds the position of PhD Associate Professor. His responsibilities have included teaching organic chemistry, supervising research, and developing educational materials.

🔬 Research Interests

Dr. Saitkulov’s research interests are centered around the synthesis and study of heterocyclic compounds, particularly quinazolin-4-one derivatives. He investigates their biological activities, including potential anthelmintic properties. His work involves exploring the biochemical effects of coordination compounds and their applications in agriculture and medicine. He is also interested in the development of environmentally friendly fertilizers and the analysis of plant-based compounds using advanced spectroscopic methods. His research contributes to the understanding of organic compounds’ roles in various biological processes.ResearchGate+6http://generis-publishing.com/+6LIBROTERRA+6Premier Publishing

🏆 Awards

Dr. Saitkulov has been recognized for his significant contributions to organic chemistry through various awards and honors. His innovative research on quinazolin-4-one derivatives and their biological activities has garnered attention in scientific circles. He has received accolades for his publications and presentations at national and international conferences. His dedication to teaching and mentoring students has also been acknowledged by academic institutions. These awards reflect his commitment to advancing the field of organic chemistry and his impact on scientific research and education.

📚Top Noted Publications

Dr. Saitkulov has an extensive publication record, including over 120 scientific articles and theses. Notable publications include:

1. **Synthesis and Study of the Processes of Biochemical Action of the Coordination Compound of Cobalt(II) Nitrate Quinazolin-4-One with 3-Indolyl Acetic Acid in Amber Plants**

Authors: [Add if applicable]
Year: 2022
Publisher: Premier Publishing
Summary: This work explores the synthesis of a cobalt(II) nitrate coordination compound with quinazolin-4-one and its biochemical action in Amber plants, focusing on potential growth stimulation via interaction with 3-indolyl acetic acid (a known auxin).
Indexing/Availability: ResearchGate [+1]

2. Synthesis of Stimulants Based on Heterocyclic Compounds Quinazolin-4-One

Authors: [Add if applicable]
Year: 2024
Publisher: LIBROTERRA
Summary: This study focuses on the design and chemical synthesis of stimulants using quinazolin-4-one as a heterocyclic scaffold, with possible applications in plant growth regulation or pharmaceutical precursors.
Indexing/Availability:
- Zien Journals [+6]
- ResearchGate [+6]

3. Investigation of Aromatic Properties of Xinazolin-4-One

Authors: [Add if applicable]
Year: 2024
Publisher: Premier Publishing
Summary: Focused on the structural and electronic aromatic characteristics of “Xinazolin-4-One” (presumably a structural analog or variation of quinazolin-4-one), this work includes computational or spectroscopic analysis to characterize aromatic stability.
Indexing/Availability: [Add source or DOI if available]

4. Synthesis of Some Quinazolin-4-One Series Heterocyclic Compounds and Their Biological Activities

Authors: [Add if applicable]
Year: 2024
Publisher: LIBROTERRA
Summary: This paper details the synthetic pathways of multiple quinazolin-4-one derivatives and evaluates their biological properties, potentially including antimicrobial or growth-promoting activities.
Also available via: Generis Publishing [+1]

Conclusion

Dr. Saitkulov Foziljon Ergashevich is a strong candidate for the Best Researcher Award, with substantial contributions to organic chemistry research and education over two decades. His track record of publication, compound synthesis, and educational resource development speaks to both academic rigor and real-world impact. With increased international exposure and research collaborations, he holds great potential to further enhance his scientific influence. Therefore, he is well-suited for recognition through this award, especially in categories emphasizing national leadership, innovation, and dedication to chemical sciences.

Xiaoqiang Chang | Molecular Medicine | Best Research Article Award

Published on 21/04/202521/04/2025 by Molecular Biologist

Dr. Xiaoqiang Chang | Molecular Medicine | Best Research Article Award

Doctorate, at School of Pharmacy, China.

Dr. Xiaoqiang Chang (常小强) is a dedicated pharmaceutical researcher currently serving at the School of Pharmacy, Bengbu Medical College (蚌埠医科大学). He earned his Ph.D. and Master’s degrees in Traditional Chinese Pharmacy from the China Academy of Chinese Medical Sciences, and his Bachelor’s from Henan University of Chinese Medicine. His research is focused on innovative methodologies in medicinal compound synthesis, particularly in the field of natural products and green catalysis. With notable publications in Environmental Chemistry Letters, Advanced Synthesis & Catalysis, and Molecules, he has proven his expertise as a unique first author. His academic journey reflects a consistent commitment to advancing pharmaceutical sciences, combining electrochemical, chromatographic, and synthetic techniques to explore medicinal compounds. Dr. Chang also holds a Chinese patent on diphenyldiazepine derivatives. His contributions continue to bridge traditional Chinese medicine with modern pharmaceutical innovation. 🌿⚗️📚

Professional Profile

🎓 Education

Dr. Xiaoqiang Chang’s academic foundation is deeply rooted in Traditional Chinese Medicine. He began his journey at Henan University of Chinese Medicine (2013-2017), earning a Bachelor’s degree in Pharmaceutical Preparation of Traditional Chinese Medicine. Driven by a passion for scientific research, he pursued graduate studies at the prestigious China Academy of Chinese Medical Sciences, obtaining a Master’s degree (2017-2020) and then a Doctorate in Chinese Pharmacy (2020-2023). During his doctoral training, Dr. Chang focused on natural product chemistry and drug development, incorporating both ancient medicinal knowledge and modern synthetic chemistry. His academic track equipped him with cross-disciplinary skills in chromatography, catalysis, and compound synthesis. His research is characterized by a fusion of heritage and innovation, reinforcing the relevance of traditional medicine in contemporary pharmaceutical sciences. 🎓🔬📖

💼 Experience

Dr. Chang began his professional research career as an Assistant Researcher at the Henan Academy of Sciences, specifically at the Biomass Pyrolysis Transformation Innovation Center (July 2023 – May 2024). Here, he investigated catalytic processes for converting biomass into pharmacologically active compounds, applying both chemical engineering and pharmaceutical expertise. In June 2024, he joined the School of Pharmacy, Bengbu Medical College, further expanding his work in drug development and compound synthesis. His transition from biomass research to pharmaceutical innovation reflects his versatile research capabilities. Despite not having postdoctoral experience, Dr. Chang has successfully led multiple projects and published extensively. His roles have not only included laboratory research but also academic mentorship and interdisciplinary collaboration, making him a rising figure in applied pharmaceutical sciences. 🔍🏥🧪

🔬 Research Interest

Dr. Chang’s research interest lies at the intersection of natural product chemistry, electrochemical synthesis, and green pharmaceutical technology. He is particularly intrigued by boron-catalyzed hydrosulfonylation, [3+2] electrochemical cycloaddition, and chromatographic techniques for active compound analysis. His recent work has focused on discovering and optimizing synthesis routes for medicinally relevant heterocycles and sulfones. Dr. Chang is passionate about developing sustainable and selective synthetic pathways, aiming to minimize environmental impact while maximizing pharmaceutical efficacy. In addition, his background in Traditional Chinese Medicine enriches his understanding of herbal pharmacology, leading to a unique integration of ancient wisdom and modern methodology. This cross-disciplinary approach is evident in both his experimental design and publication record. His long-term vision is to establish eco-friendly, high-efficiency platforms for drug discovery from both synthetic and natural sources. 🌱🧬⚙️

🏆 Awards

Although Dr. Chang has yet to receive national-level funding or formal academic awards, his contribution to pharmaceutical research has been formally recognized through intellectual property achievements. In June 2023, he co-authored a Chinese patent titled “二苯并二氮杂卓衍生物及其制备方法和应用” (Diphenyldiazepine derivatives and their preparation method and application), registered as CN202310743034.9. This patent underscores his ability to transition basic chemical findings into practical applications, a key metric in modern pharmaceutical evaluation. The novelty and application potential of the compound structure demonstrate both innovation and therapeutic foresight. While still early in his career, Dr. Chang’s consistent authorship as the sole first author across several high-impact journal articles signifies his scientific independence and leadership. His continued work promises future recognition and contributions to medical chemistry and drug discovery. 🧪📜🚀

📚 Top Noted Publications

1.Title: Synthesis of branched allylic sulfones by regioselective boron-catalysed hydrosulfonylation
Journal: Environmental Chemistry Letters
Year: 2023
Volume: 21
Pages: 681–687
Citations: 7
Summary:
This paper reports a novel method for synthesizing branched allylic sulfones using a regioselective boron-catalyzed hydrosulfonylation reaction. The methodology showcases high efficiency and selectivity, contributing significantly to sustainable synthetic chemistry and green catalysis.

2.Title: Electrochemical [3+2] Cycloaddition of Anilines and 1,3‐Dicarbonyl Compounds
Journal: Advanced Synthesis & Catalysis
Year: 2022
Volume: 364(16)
Pages: 2865–2871
Citations: 12
Summary:
This article presents an electrochemical approach for [3+2] cycloaddition between anilines and 1,3-dicarbonyl compounds. It demonstrates a metal-free and environmentally friendly route, offering a valuable synthetic tool in heterocyclic chemistry.

3.Title: A novel flavanone from Thymus przewalskii
Journal: China Journal of Chinese Materia Medica (中国中药杂志)
Year: 2021
Volume: 46(1)
Pages: 125–129
Citations: 4
Summary:
This study details the isolation and structural elucidation of a new flavanone compound from Thymus przewalskii. The findings enhance understanding of the phytochemistry of traditional Chinese medicinal herbs.

4.Title: Determination of Thymol and Carvacrol in Thymi herba by UPC2
Journal: Molecules
Year: 2020
Volume: 25
Article Number: 502
Citations: 16
Summary:
This paper describes a fast and reliable ultra-performance convergence chromatography (UPC2) method to quantify thymol and carvacrol in Thymi herba. It is significant for quality control in herbal medicine and pharmaceutical applications.

5.Title: 地椒质量标准的研究 (Study on the Quality Standards of Di Jiao)
Journal: 中成药 (Chinese Patent Medicine)
Year: 2019
Volume: 41(8)
Pages: 1894–1898
Citations: 5
Summary:
This article explores the establishment of quality control standards for Di Jiao (地椒), a traditional Chinese medicinal material. It involves pharmacognostic and chemical evaluation techniques to ensure consistency and efficacy.

Conclusion

Dr. Xiaoqiang Chang demonstrates clear scientific excellence, with a consistent track record of innovative, independently-led publications in high-impact journals and contribution to intellectual property development. While additional involvement in research grants and broader academic leadership would strengthen the application, his current scholarly output makes him highly competitive for the Best Research Article Award. His first-author articles reflect originality, depth, and relevance—hallmarks of an outstanding candidate.

Weijun Shen | Porous Flow in Reservoirs | Best Researcher Award

Published on 21/04/202521/04/2025 by Molecular Biologist

Prof. Weijun Shen | Porous Flow in Reservoirs | Best Researcher Award

professor, at Institute of Mechanics, Chinese Academy of Sciences, China.

Dr. Weijun Shen is an Associate Professor at the Institute of Mechanics, Chinese Academy of Sciences (CAS), specializing in advanced fluid mechanics and reservoir engineering. 🎓 He earned his undergraduate degree from Southwest Petroleum University in 2010 and completed his PhD in Fluid Mechanics at the University of Chinese Academy of Sciences in 2016. As a joint PhD researcher, he spent time at the Lawrence Berkeley National Laboratory (LBNL) under the University of California, Berkeley from 2014 to 2016. 🇨🇳🇺🇸 Dr. Shen’s work centers on fluid flow and transport in complex geological formations, reservoir characterization, and enhanced oil recovery (EOR) technologies. As an editorial board member and active committee participant, he plays a vital role in the scientific community. 📚 With over 70 published papers, multiple patents, and several prestigious awards, Dr. Shen has made remarkable contributions to energy and environmental engineering. 🔬

Professional Profile

🎓 Education

Dr. Weijun Shen’s academic path began with a Bachelor’s degree in Petroleum Engineering from Southwest Petroleum University in 2010. 🛢️ He then pursued a Ph.D. in Fluid Mechanics at the University of Chinese Academy of Sciences (UCAS), where he focused on complex subsurface flow dynamics. 🌊 During his doctoral studies from 2014 to 2016, he conducted joint research at the Energy Geosciences Division of Lawrence Berkeley National Laboratory (LBNL) in collaboration with the University of California, Berkeley. This international research experience allowed him to refine his expertise in computational modeling and enhanced oil recovery techniques, combining theoretical and applied knowledge. 🌍 His solid educational background laid the foundation for his interdisciplinary approach, blending physics-based modeling with petroleum engineering applications. 🎯 Dr. Shen’s academic credentials reflect a commitment to high-level scientific training and international collaboration in energy and geoscience research. 📘

💼 Experience

Dr. Weijun Shen serves as an Associate Professor at the Institute of Mechanics, Chinese Academy of Sciences, where he leads advanced research in fluid mechanics and reservoir engineering. 👨‍🔬 He began his academic journey with a strong background in petroleum studies and evolved into a researcher bridging fluid dynamics and energy technologies. His tenure at the Lawrence Berkeley National Laboratory (2014–2016) offered practical insights into global energy challenges and advanced numerical simulations. 🔍 Dr. Shen contributes significantly as an Associate Editor for the Journal of Petroleum Exploration and Production Technology and actively participates in the Beijing-Tianjin-Hebei Expert Committee under the Beijing Energy and Environment Society. 🏛️ With over a decade of experience, he has supervised projects focused on reservoir modeling, EOR, and sustainable subsurface energy systems. His ability to integrate industry and academic perspectives has earned him recognition within China and abroad. 🌐

🔬 Research Interest

Dr. Shen’s research explores the fluid flow and transport phenomena in geological formations, specifically in subsurface reservoirs used for oil extraction and carbon storage. 🌐 His interests cover reservoir characterization, enhanced oil recovery (EOR), and numerical simulation techniques to model complex underground environments. 💧 He investigates multiphase and multicomponent transport systems to optimize fluid injection strategies in low-permeability formations. His studies incorporate advanced computational models, machine learning integration for permeability predictions, and innovative fluid-rock interaction models. 🧠 His interdisciplinary work connects fluid mechanics, petroleum engineering, and energy sustainability, contributing to improved oil recovery while addressing energy transition goals. He is also involved in reservoir fracture analysis and the development of CO₂-EOR strategies to support carbon neutrality initiatives. 🌱 His research supports both the scientific community and the energy sector, delivering practical solutions with high societal and environmental impact. 📊

🏆 Awards

Dr. Weijun Shen has received more than 10 provincial-ministerial and industry science and technology awards, recognizing his impactful research in petroleum engineering and reservoir simulation. 🏅 His innovative contributions to enhanced oil recovery and numerical reservoir modeling have made significant advances in both academic and industrial sectors. His achievements include awards for excellence in science and innovation from Chinese government bodies and professional societies. 🥇 These accolades celebrate his deep commitment to developing energy-efficient and environmentally sustainable reservoir systems. Additionally, he has earned commendations for international research collaborations, notably during his time at Lawrence Berkeley National Laboratory. 🌎 His recognition as an emerging thought leader in fluid transport and reservoir dynamics underscores the importance of his work in China’s energy transition. Dr. Shen continues to contribute solutions to the global energy landscape, exemplifying leadership and scientific excellence. 🧪

📚 Top Noted Publications

Dr. Weijun Shen has authored over 70 peer-reviewed papers, 2 monographs, and holds 20 patents, underscoring his prolific scientific output in the field of fluid mechanics and reservoir engineering. His publications appear in prestigious journals such as the Journal of Hydrology, Fuel, Journal of Petroleum Science and Engineering, and Advances in Water Resources. 📝 His most-cited works focus on enhanced oil recovery modeling, multiphase flow in porous media, and reservoir simulation frameworks. Many of his papers have been cited extensively, reflecting his influence in the scientific community. Some highlighted works include:

Shen, W., et al. (2019). “Modeling multiphase flow in fractured reservoirs using an improved lattice Boltzmann method”, Journal of Hydrology – cited by 105 articles.
Shen, W., et al. (2021). “Enhanced oil recovery using foam-assisted CO₂ flooding”, Fuel – cited by 83 articles.
Shen, W., et al. (2020). “Numerical simulation of miscible gas injection in heterogeneous reservoirs”, Journal of Petroleum Science and Engineering – cited by 72 articles.

Conclusion

Dr. Weijun Shen is an exceptionally strong candidate for the Best Researcher Award. His prolific academic output, impactful patents, leadership roles, and national-level recognition make a compelling case. With continued emphasis on international engagement and interdisciplinary collaboration, his already impressive profile could become truly world-leading.

Constantin-Ioan Busuioc | Molecular Pathology | Best Researcher Award

Published on 15/04/202515/04/2025 by Molecular Biologist

Dr. Constantin-Ioan Busuioc | Molecular Pathology | Best Researcher Award

Pathologist, at Saint Mary Clinical Hospital, Romania.

Dr. Constantin-Ioan Busuioc is a distinguished Romanian pathologist with a strong background in both clinical and research domains. Born on January 29, 1985, he has devoted his career to exploring the intricate dynamics of pathology, with special focus on oncologic and hematologic conditions. He is currently affiliated with Saint Mary Clinical Hospital in Bucharest, where he plays a pivotal role in surgical specimen analysis and histopathological diagnostics. Over the years, Dr. Busuioc has amassed considerable experience across institutions in Romania, Switzerland, and Italy, enriching his expertise in diagnostic pathology. His research contributions, particularly in colorectal cancer and immunohistochemistry, have gained recognition in high-impact journals. Known for his clinical precision and academic depth, he bridges the gap between research and real-world pathology. Dr. Busuioc is fluent in English and French, and actively participates in both national and international medical networks. 🧬💉🧪

Professional Profile

🎓 Education

Dr. Constantin-Ioan Busuioc’s educational journey exemplifies dedication to academic excellence in medicine. He completed his Medical Doctor (M.D.) degree at the University of Medicine and Pharmacy “Iuliu Haţieganu” in Cluj-Napoca, Romania (2005–2011) 🩺. Subsequently, he pursued a Ph.D. at the same institution from 2015 to 2022, delving into molecular and immunohistochemical aspects of malignancies, particularly colorectal adenocarcinoma. His rigorous research training culminated in several significant publications and conference presentations. In 2021, he obtained a Certificate in Health Services Management from the National School of Public Health, Management and Training, enhancing his administrative and healthcare policy knowledge 📊. Additionally, he undertook a fellowship in Hematopathology at the prestigious European Institute of Oncology in Milan, Italy, under Prof. Dr. Stefano A. Pileri. This diverse academic path has equipped him with a well-rounded perspective, blending clinical pathology, biomedical research, and health systems management. 📚🧠

🏥 Experience

With over a decade of professional experience, Dr. Busuioc has held key pathology roles across several European institutions. His current role at Saint Mary Clinical Hospital (since 2023) involves high-stakes diagnostics, intraoperative evaluations, and necropsies. From 2021 to 2023, he served at the National Institute of Infectious Diseases “Prof. Dr. Matei Balș”, specializing in infectious pathology, autopsies, and immunohistochemistry. 🧫 Earlier roles include long-term service at Oncoteam Diagnostic and previous tenure at Synevo, where he managed complex diagnostic cases involving general and hematopathology. Internationally, he worked as Chef de Clinique at Valais Hospital in Switzerland (2018–2019) and completed an intensive fellowship at the European Institute of Oncology, Italy. His foundational years were spent as a resident at Cluj-Napoca County Hospital, with rotations at specialized hospitals including the Oncology Institute and Gastroenterology Institute. His vast experience shapes his precision in diagnosis and depth in pathology. 🧬🦠

🧠 Research Interests

Dr. Busuioc’s research interests lie at the intersection of molecular oncology, immunohistochemistry, and epithelial-mesenchymal transition (EMT) in gastrointestinal malignancies, particularly colorectal and esophageal cancers. He is also intrigued by gene expression profiling, diagnostic biomarkers, and tumor microenvironment interactions. 🧬 His studies often explore the role of EMT markers like Vimentin and E-cadherin in predicting tumor progression. Utilizing bioinformatics tools, he analyzes molecular pathways and gene signatures such as MMP3 and TESC, aiming to enhance early detection and personalized treatment approaches. He has contributed significantly to the understanding of PD-L1 expression, particularly in esophageal carcinoma, and its immunological implications. Additionally, he has co-authored studies on rare case presentations such as Kikuchi-Fujimoto disease and lymphomas in gynecological tissues. His collaborative approach and interdisciplinary mindset make his research impactful and translational. 🔍🧫

🏆 Awards

Dr. Constantin-Ioan Busuioc has earned recognition for his commitment to excellence in pathology and oncology research. One of the highlights of his academic career is being part of the UEFISCDI-awarded article published in Cancers (Basel), which offered a comprehensive review of MAPK pathways as therapeutic targets in cancer. 🏅 His insightful contributions to colorectal cancer pathology and bioinformatics analysis have garnered attention in Romanian medical circles and abroad. His consistent publication in high-impact journals reflects a commendable academic rigor. He has also been nominated for multiple academic awards through Romanian and European research forums. His interdisciplinary case studies, particularly in complex co-morbidities, showcase his versatility as both a clinician and a researcher. These recognitions not only validate his scientific acumen but also reinforce his status as a dedicated and innovative medical professional. 🌟📖

📚Top Noted Publications

Dr. Busuioc has co-authored 12+ peer-reviewed articles in reputable international journals, reflecting his impactful work in pathology and molecular oncology:

Aberrant Immunohistochemical Expression in Colorectal Adenocarcinoma
Chirurgia (Bucur), 2022
- Focus: Aberrant IHC patterns in colorectal cancer
- Citations: 5
- Notes: Highlights novel expression markers potentially linked to prognosis and therapy responsiveness.
MMP3 & TESC in Colon Adenocarcinoma
BioMedInformatics, 2022
- Focus: Role of MMP3 and TESC genes in colon cancer progression using computational biology tools
- Citations: 2
EMT Gene Signature & Prognosis in Colon Adenocarcinoma
Journal of Personalized Medicine, 2021
- Focus: EMT-related gene expression linked to prognosis and patient stratification
- Citations: 10
- Impact: Widely referenced in personalized therapy literature.
PD-L1 Expression in Esophageal Carcinomas
Chirurgia (Bucur), 2022
- Focus: PD-L1 immunostaining in esophageal cancer subtypes
- Notes: Adds data to the ongoing debate on immunotherapy eligibility.
MAPK Pathways Review: Biological Mechanisms & Therapeutic Targets in Oncology
Cancers (Basel), 2019
- Focus: Comprehensive review of MAPK signaling in cancer
- Citations: 100+
- Recognition: Award-winning article, highly cited in targeted therapy discussions.
Multidisciplinary Team in Rectal Cancer Management: Integration & Outcomes
Clujul Med, 2017
- Focus: Clinical coordination in colorectal cancer treatment
- Notes: Addresses practical framework for collaborative cancer care.

🩺 Internal Medicine, Autoimmunity & Rare Conditions

Case of Acute Polyarthritis with Severe Comorbidity
Internal Medicine, 2021
- Focus: Complex internal medicine case with overlapping rheumatological and systemic features
Sarcoidosis Associated with Solid Pseudopapillary Tumor: A Diagnostic Rarity
Romanian Journal of Internal Medicine, 2022
- Focus: Uncommon tumor presentation in a patient with sarcoidosis
Episcleritis in Granulomatosis with Polyangiitis: A Diagnostic Challenge
Romanian Journal of Ophthalmology, 2021
- Focus: Ocular manifestation of a systemic vasculitis
Kikuchi-Fujimoto Disease Mimicking Systemic Lupus Erythematosus
Romanian Journal of Rhinology, 2022
- Focus: Autoimmune overlap and diagnostic pitfalls
Primary Gynecological Lymphomas: A Behavioural Case Perspective
Annals of Behavioural Science, 2018
- Focus: Behavioral and clinical aspects of gynecological lymphoma diagnosis and management

Conclusion

Dr. Constantin-Ioan Busuioc is a strong candidate for a Best Researcher Award, especially in the field of oncopathology, molecular diagnostics, and histopathology. His blend of clinical practice, interdisciplinary research, and international experience makes him highly competitive. With enhanced visibility in research leadership roles and international scholarly forums, his profile would be further elevated to a global best researcher standard.

King-cheong LAM | Molecular Biology | Best Researcher Award

Published on 11/04/202511/04/2025 by Molecular Biologist

Dr. King-cheong LAM | Molecular Biology | Best Researcher Award

Senior Lecturer, at The School of Professional Education and Executive Development (SPEED), The Hong Kong Polytechnic University, Hong Kong.

Dr. LAM King-cheong Antony is a seasoned academic currently serving as a Senior Lecturer in the Division of Science, Engineering and Health Studies at the College of Professional and Continuing Education (CPCE), The Hong Kong Polytechnic University. With a rich interdisciplinary background in physics and engineering education, Dr. Lam has consistently contributed to innovative teaching methods and research initiatives. His career journey from a secondary school teacher to a respected university lecturer is marked by dedication to student development, academic leadership, and community outreach. 📘 His roles as Programme Leader and Co-Investigator in prestigious funded projects reflect his commitment to applied research and educational advancement. Through his work in nanotechnology, sustainable energy, and smart sensor systems, Dr. Lam exemplifies a professional devoted to shaping the future of science education and technology for sustainable urban living. 🌱

Professional Profile

🎓 Education

Dr. Antony Lam’s academic path is built on a solid foundation in science and education. 🎓 He earned his Doctor of Philosophy from The Hong Kong Polytechnic University in 2017, where he focused on gas sensing materials using graphene-based composites. Prior to that, he completed his Master of Philosophy (2008) and Bachelor of Science in Physics (2005) at The University of Hong Kong, establishing his grounding in physical sciences. Recognizing the importance of pedagogy in science, he also pursued a Postgraduate Diploma in Education from The University of Hong Kong in 2010, equipping himself with the skills to bridge research and teaching. This rare blend of scientific rigor and educational expertise empowers him to mentor students and lead cross-disciplinary research with confidence. 🧠 His training has laid the foundation for a career devoted to both scientific discovery and academic development.

💼 Experience

Dr. Lam’s professional career spans across secondary and tertiary education sectors. 🏫 From 2007 to 2012, he began his journey as a science teacher at Heung To Secondary School (TKO), where he nurtured young minds with enthusiasm for physics. In 2018, he transitioned to higher education as a Lecturer at CPCE, The Hong Kong Polytechnic University, and was promoted to Senior Lecturer in 2024. Over the years, Dr. Lam has taken on several key academic leadership roles, including Programme Leader for Associate in Engineering and Higher Diploma in Aircraft Services Engineering, and Assistant Programme Leader for the BEng (Hons) in Mechanical Engineering. 💼 These positions not only reflect his pedagogical expertise but also his capability in curriculum innovation and academic governance. Dr. Lam’s dedication to bridging practical engineering with academic training is central to his career mission of advancing applied science education. ⚙️

🔬 Research Interests

Dr. Lam’s research interests lie at the intersection of nanotechnology, green energy, sustainable materials, and smart sensing systems. 🌍 His work explores the fabrication of advanced materials such as tin-based perovskites, graphene composites, and aluminum-ion batteries to enhance energy efficiency and sensor capabilities. A significant part of his research addresses real-world sustainability challenges—ranging from developing natural fiber/concrete composites for eco-friendly buildings to ionic-liquid-based gas sensors for smart cities. 🏙️ He is also actively investigating thermal and mechanical properties of biomaterials, including mycelium-based composites for biomedical applications. His interdisciplinary approach combines physics, chemistry, and engineering to produce applicable technologies for energy and healthcare sectors. Through multiple funded projects and international conferences, Dr. Lam has established himself as a researcher committed to translational science for societal impact. 🌱

🏅 Awards

Dr. Lam’s research excellence has earned him both institutional recognition and competitive external grants. 🏆 In 2023, he received the KML Third Prize (HK$200,000) from the Koo Meng Li and Koo Mi Wen Na Charitable Foundation Limited for his project on natural fiber/concrete composites for sustainable buildings. He has been a Principal Investigator and Co-Investigator in numerous high-impact projects, including a nearly HK$1 million RGC-funded project on mycelium-based insoles for diabetic care. 💰 These awards and grants highlight his innovative work in sustainable technology and material science. Dr. Lam’s recognition not only reflects his technical acumen but also his leadership in building collaborative, real-world solutions. His consistent involvement in cutting-edge research underscores his role as a forward-thinking academic in science and engineering education. 🧪

📚 Top Noted Publications

Dr. Lam has contributed to a number of peer-reviewed journals and conferences in the fields of materials science, physics, and engineering education. His most cited works involve graphene-based sensors, perovskite solar cells, and AR learning systems. 📖 His publication list includes:

1. Ahmed, S. B., Kan, H. W., Lam, K. C., & Yip, C. T. (2025)

Title: Charge-induced isomerization in alkyl imine molecular motors: a reduced energy barrier approach
Journal: RSC Advances, 15(10), 8053–8059.

Focus: Investigates charge-induced isomerization mechanisms in alkyl imine-based molecular motors.
Contribution: Proposes a novel approach to reducing the energy barrier for directional motion.
Significance: Offers insights into molecular machines and nanoscale actuation.

2. Wang, Y. D., et al., incl. Lam, K. C. (2024)

Title: Direct manipulation of diffusion in colloidal glasses via quasi-particle-like defects
Journal: Physical Review E, 110(6), 064603.

Focus: Explores defect-driven dynamics in colloidal glasses.
Contribution: Demonstrates how quasi-particle-like defects can directly control diffusion.
Significance: Advances fundamental understanding of amorphous materials and soft matter physics.

3. Li, K. C., Lam, K. C., et al. (2024)

Title: Designing ultrathin ferromagnetic nanowires for Majorana mode studies
Journal: Results in Physics, Article ID 107322.

Focus: Investigates ferromagnetic nanowires for potential topological quantum computing applications.
Contribution: Proposes new nanowire designs optimized for stabilizing Majorana zero modes.
Significance: Supports progress in solid-state quantum computation.

4. Lo, K., Ng, J., Chau, & Lam, A. (2023)

Title: AR-based mobile learning for electrical fundamentals
Journal: Journal of Online Engineering Education, 14(2), 01–12.

Focus: Combines augmented reality (AR) with mobile learning for engineering education.
Contribution: Assesses effectiveness of interactive AR tools for teaching basic electrical concepts.
Significance: Enhances engagement and learning outcomes in STEM education.

5. Lam, K. C., Huang, B., & Shi, S. Q. (2017)

Title: Room-temperature methane gas sensing with graphene-SnO₂
Journal: Journal of Materials Chemistry A, 5, 11131–11142.

Focus: Develops graphene-SnO₂ composites for methane sensing at ambient temperature.
Contribution: Demonstrates high sensitivity and fast response/recovery cycles.
Significance: Highly cited (over 300 citations on Google Scholar)—a foundational paper in gas sensor development using nanomaterials.

Conclusion

Dr. LAM King-cheong Antony is highly suitable for consideration for a Best Researcher Award. His record showcases a consistent trajectory of impactful, interdisciplinary research, successful funding, academic service, and innovation. With growing momentum in both fundamental and applied sciences, and continued leadership within CPCE, he exemplifies the qualities of a committed and forward-thinking researcher. Acknowledging him with such an award would recognize not only his past achievements but also encourage his ongoing contributions to science and engineering.

Rokaia Lejri | Biotechnology | Best Researcher Award

Published on 11/04/202511/04/2025 by Molecular Biologist

Dr. Rokaia Lejri | Biotechnology | Best Researcher Award

Doctorate, at Faculty of science of Gafsa, Tunisia.

Dr. Rokaia Lejri is a dedicated Tunisian researcher specializing in Biological Sciences and Biotechnology. With a strong academic background rooted in the Faculty of Sciences of Gafsa, Tunisia, she has consistently focused on environmental microbiology and industrial wastewater bioremediation. Her doctoral research investigates the toxicity and treatment of effluents from the tannery industry, a pressing ecological concern in Tunisia. Throughout her career, she has conducted several research internships across Tunisia and Spain, working on microbial genomics, effluent analysis, and bioremediation strategies. Dr. Lejri has contributed significantly to scientific literature through high-impact publications and actively participates in international symposia and academic forums. She is proficient in multiple languages and scientific software, which enhances her global research collaboration potential. Passionate about sustainable development and environmental protection, she strives to develop innovative solutions for industrial pollution using microbiological and molecular tools.

Professional Profile

🎓 Education

Dr. Rokaia Lejri pursued her academic journey entirely at the University of Gafsa, Tunisia. From 2012 to 2016, she earned a Bachelor’s degree in Cellular and Molecular Biology and Biotechnology, followed by a Master’s in Biology and Environment (2016–2018). Her master’s thesis focused on the phytotoxicity of effluents from the Gafsa tanning company, laying the groundwork for her later research. In 2020, she began her Ph.D. in Biological Sciences and Biotechnology at the same institution. Her doctoral research centered on the toxicity characterization and biological treatment of industrial tannery effluents in Kasserine, Tunisia. She worked under the guidance of the Laboratory of Ecosystems and Biodiversity in Arid Environments of Tunisia (LEBIOMAT). Additionally, she completed multiple internships in clinical, hospital, and environmental laboratories, including at the University of Valencia, Spain. These experiences fortified her interdisciplinary skills in microbiology, biochemistry, and molecular biology.

💼 Experience

Dr. Lejri’s career is marked by diverse and intensive laboratory experiences. She completed nine internships ranging from hospital biochemistry labs to high-level genomic research in Spain. Her thesis internships include microbiological, biochemical, and genomic studies of wastewater from Tunisian tanneries. Notably, at the University of Valencia, she participated in genomic characterization of bacteria for taxonomic and bioremediation studies. Domestically, she worked at the Gafsa Sanitation Office and Hygiene Laboratory, performing in-depth analysis of industrial effluents. Her practical experience includes Atomic Absorption Spectrometry (AAS) for heavy metal detection, microbial isolation, DNA extraction, and NGS data analysis. She has co-supervised both bachelor’s and master’s theses, mentoring students in experimental design and environmental microbiology. Fluent in Arabic, French, English, and Spanish, she seamlessly integrates into international research teams. Dr. Lejri’s professional journey exemplifies a strong balance of fieldwork, analytical lab expertise, and academic mentorship.

🔍 Research Interest

Dr. Rokaia Lejri’s research interests revolve around industrial wastewater bioremediation, microbial ecology, and environmental toxicology. She specializes in the isolation, characterization, and genomic profiling of metal-resistant bacteria from industrial effluents, with a focus on their biotechnological potential for environmental clean-up. Her work combines microbiology, molecular biology, and biochemistry to assess the eco-toxicological impact of tanning industry effluents. She is particularly interested in the use of next-generation sequencing (NGS) and bioinformatics tools for genome annotation and functional prediction of microbial strains. Her current focus includes identifying novel strains suitable for heavy metal bioremediation and understanding the mechanisms of toxicity removal. Through interdisciplinary collaborations, she aims to bridge gaps between academia, industry, and environmental policy, contributing sustainable solutions for pollution control. She also advocates for the integration of molecular tools in routine environmental assessments to enhance the precision and efficiency of bioremediation protocols.

🏆 Awards

Dr. Rokaia Lejri’s academic journey has earned her recognition within the research community. She has received conference presentation awards for her work on the bioremediation potential of bacterial strains from tannery effluents at both national and international symposia. She was an invited speaker and presenter at the 19th International Symposium on Microbial Ecology (ISME19) in South Africa (2024), highlighting the global relevance of her research. Her contributions were also well-received at the 9th International Scientific Days on Health and Environmental Protection in Tunisia and at biodiversity forums in Morocco. In addition to being recognized for oral and poster presentations, Dr. Lejri has co-supervised graduate research projects, further demonstrating her commitment to academic development and mentorship. Her collaborative spirit and outstanding contributions to environmental microbiology continue to bring her esteem within the scientific community.

📚 Top Noted Publications

Dr. Lejri has published several peer-reviewed articles in high-impact journals, showcasing her expertise in environmental microbiology:

1. Physico-Chemical, Microbial and Toxicity Assessment of Industrial Effluents from the Southern Tunisian Tannery

Journal: Journal of Water Process Engineering, 2022
DOI: 10.1016/j.jwpe.2022.102686 OUCI
Authors: Rokaia Lejri, Sonia Ben Younes, Ali Ellafi, Amir Bouallegue, Younes Moussaoui, Mohamed Chaieb, Ali Mekki producciocientifica.uv.es+2OUCI+2SSRN+2
Highlights:
- Comprehensive analysis of untreated tannery effluent from Kasserine, Tunisia.SSRN
- Physicochemical studies revealed high levels of pollutants, including heavy metals and organic matter.
- Microbial assessments indicated significant bacterial contamination.
- Toxicity tests demonstrated adverse effects on aquatic organisms, emphasizing the need for effective treatment solutions.

2. Phenotypic Characterization for Bioremediation Suitability of Isolates from Southern Tunisian Tannery Effluent

Journal: Microbiological Research, 2024
DOI: 10.1016/j.micres.2024.127771 producciocientifica.uv.es+1OUCI+1
Authors: Rokaia Lejri, Ali Ellafi, Juan Valero Tebar, Mohamed Chaieb, Ali Mekki, Mária Džunková, Sonia Ben Younes producciocientifica.uv.es+2OUCI+2SSRN+2
Highlights:
- Isolation and analysis of seven Enterococcus faecium and two Bacillus subtilis strains from tannery effluent.PubMed
- Evaluation of phenotypic traits such as biofilm formation, hydrophobicity, and exoenzyme activities relevant to bioremediation.PubMed
- Assessment of antibiotic resistance and pathogenicity indicators to ensure environmental safety.PubMed
- Identification of strains with high bioremediation potential without pathogenic traits, suitable for eco-friendly wastewater treatment.PubMed

3. Genomic Features of Metal-Resistant Bacteria Suitable for Tannery Effluent Bioremediation

Journal: Journal of Water Process Engineering, 2024
DOI: 10.1016/j.jwpe.2024.106406 OUCI
Authors: Rokaia Lejri, Ali Mekki, Ali Ellafi, Selma Henchiri, Joel Giner Tarazón, Juan Valero Tebar, Giuseppe D’Auria, Mohamed Chamkha, Mohamed Chaieb, Mária Džunková, Sonia Ben Younes SSRN+2OUCI+2producciocientifica.uv.es+2
Highlights:
- Genomic analysis of metal-resistant bacterial strains isolated from tannery effluent.
- Identification of genes responsible for heavy metal resistance and bioremediation capabilities.
- Insights into metabolic pathways facilitating the degradation of pollutants.
- Potential application of these strains in developing effective bioremediation strategies for industrial wastewater.

Conclusion

Dr. Rokaia Lejri exhibits outstanding qualities of a modern researcher: scientific rigor, interdisciplinary expertise, global collaboration, and a strong publication record in high-impact journals. Her work on the bioremediation of industrial effluents, including genomic and phenotypic characterization of metal-resistant bacteria, holds substantial promise for environmental innovation.

Christo Nanev | Proteomics | Best Researcher Award

Published on 11/04/202511/04/2025 by Molecular Biologist

Prof. Dr. Christo Nanev | Proteomics | Best Researcher Award

Professor Doctorate, at INST PHYSICAL CHEMISTRY BAS, Bulgaria.

Prof. Christo N. Nanev is a distinguished Bulgarian physical chemist renowned for his pioneering contributions to crystal growth and nucleation. He earned his PhD under the mentorship of Academician Rostislaw Kaischew and later achieved a Doctor of Science degree in Physical Chemistry from the Bulgarian Academy of Sciences. His research spans various domains, including protein crystallization, semiconductor thin films, and electrocrystallization. Notably, his images of insulin crystals were featured in the 8th edition of the textbook “Biochemistry” by Berg et al. Prof. Nanev has authored over 150 scientific papers and holds five patents. He serves on the Advisory Board of Crystal Research and Technology and is a fellow of the Humboldt Union in Bulgaria. As the principal investigator of Bulgaria’s first space experiment, he was honored with the ‘Interkosmos’ medal. His work continues to influence the fields of crystallography and physical chemistry.

Professional Profile

🎓 Education

Prof. Nanev completed his undergraduate studies at the Chemical Faculty of Sofia University “St. Kliment Ohridski” in Bulgaria. During his academic tenure, he specialized in the growth of crystal whiskers at the Institute of Physics, Czechoslovak Academy of Sciences in Prague. He pursued his PhD in crystal growth under the guidance of Academician Rostislaw Kaischew, a luminary in the field. Subsequently, he attained the Doctor of Science degree in Physical Chemistry from the Bulgarian Academy of Sciences, reflecting his profound expertise and contributions to the discipline. His educational journey laid a robust foundation for his illustrious career in crystallography and physical chemistry.

🧪 Experience

With a career spanning several decades, Prof. Nanev has been at the forefront of research in crystal nucleation and growth. His experimental and theoretical work encompasses protein crystallization, semiconductor thin films, metal electrocrystallization, and the growth of quartz crystals. He has also delved into surface leveling during the deposition of galvanic coatings. His expertise has been recognized through his role as a principal investigator in Bulgaria’s inaugural space experiment, earning him the ‘Interkosmos’ medal. Beyond research, he contributes to the scientific community as a member of the Advisory Board for Crystal Research and Technology and as a fellow of the Humboldt Union in Bulgaria. His extensive experience continues to inspire advancements in the field.

🔬 Research Interests

Prof. Nanev’s research interests are deeply rooted in the mechanisms of crystal nucleation and growth. He has extensively studied protein crystallization, providing insights crucial for structural biology and pharmaceutical applications. His work on semiconductor thin films and metal electrocrystallization has implications for electronic materials and surface engineering. Additionally, he has explored the growth processes of quartz crystals and the dynamics of surface leveling in galvanic coatings. His interdisciplinary approach bridges physical chemistry with materials science, contributing to both theoretical frameworks and practical applications in crystallography.

🏅 Awards

Prof. Nanev’s contributions have been recognized through various accolades. Notably, he received the ‘Interkosmos’ medal for his role as the principal investigator in Bulgaria’s first space experiment. His election as a fellow of the Humboldt Union in Bulgaria underscores his esteemed position in the scientific community. His work has not only advanced scientific understanding but also garnered international recognition, reflecting his impact on the field of physical chemistry.

📚 Top Noted Publications

Prof. Nanev has an extensive publication record, with over 150 scientific papers and five patents. His research has been featured in reputable journals, contributing significantly to the fields of crystallography and physical chemistry. Notably, his images of insulin crystals were included in the 8th edition of the textbook “Biochemistry” by Berg et al., published by W. H. Freeman in 2015. For a comprehensive list of his publications, you can refer to his Google Scholar profile.

📌 1. Nucleation of Lysozyme Crystals Under External Electric and Ultrasonic Fields

Authors: CN Nanev, A Penkova
Journal: Journal of Crystal Growth, 232 (1–4), 285–293 (2001)
Citations: 145
DOI: Link
Summary: Explores how electric and ultrasonic fields affect the nucleation rate of lysozyme crystals. Concludes that ultrasonic fields enhance nucleation via cavitation effects, while electric fields influence nucleation through electrostatic and convection mechanisms.

📌 2. Heterogeneous Nucleation (and Adhesion) of Lysozyme Crystals

Authors: D Tsekova, S Dimitrova, CN Nanev
Journal: Journal of Crystal Growth, 196 (2–4), 226–233 (1999)
Citations: 94
DOI: Link
Summary: Investigates heterogeneous nucleation of lysozyme on various substrates, focusing on adhesion forces and how they determine crystal orientation and location.

📌 3. Temperature-Independent Solubility and Interactions Between Apoferritin Monomers and Dimers in Solution

Authors: DN Petsev, BR Thomas, ST Yau, D Tsekova, CN Nanev, WW Wilson, et al.
Journal: Journal of Crystal Growth, 232 (1–4), 21–29 (2001)
Citations: 80
DOI: Link
Summary: Explores the unique solubility behavior of apoferritin, with a focus on dimer–monomer interactions. Highlights the role of solution thermodynamics in protein crystallization.

📌 4. Protein Crystal Nucleation in Pores

Authors: CN Nanev, E Saridakis, NE Chayen
Journal: Scientific Reports, 7 (1), 35821 (2017)
Citations: 56
DOI: Link
Summary: Shows how nanoscale confinement can be used to initiate and control protein nucleation. Potentially important for crystallizing proteins that are otherwise difficult to nucleate.

📌 5. Kinetics of Insulin Crystal Nucleation, Energy Barrier, and Nucleus Size

Authors: CN Nanev, FV Hodzhaoglu, IL Dimitrov
Journal: Crystal Growth & Design, 11 (1), 196–202 (2011)
Citations: 56
DOI: Link
Summary: Analyzes insulin crystallization kinetics to determine the energy barrier and size of critical nuclei using experimental and theoretical models.

📌 6. Enhancement and Suppression of Protein Crystal Nucleation Due to Electrically Driven Convection

Authors: A Penkova, O Gliko, IL Dimitrov, FV Hodjaoglu, CN Nanev, PG Vekilov
Journal: Journal of Crystal Growth, 275 (1–2), e1527–e1532 (2005)
Citations: 56
DOI: Link
Summary: Demonstrates how convection currents caused by electric fields influence nucleation via spatial inhomogeneities of supersaturation.

📌 7. On the Slow Kinetics of Protein Crystallization

Author: CN Nanev
Journal: Crystal Growth & Design, 7 (8), 1533–1540 (2007)
Citations: 50
DOI: Link
Summary: Proposes that kinetic barriers and specific protein interactions cause delays in nucleation, explaining difficulties in crystallizing many proteins.

📌 8. Theory of Nucleation

Author: CN Nanev
In: Handbook of Crystal Growth (Second Ed.), Ed. Nishinaga T., Vol. 1, 315–358 (2015)
Citations: 47
Summary: A comprehensive chapter covering classical and non-classical nucleation theories, including the effect of impurities and solution dynamics.

📌 9. Heterogeneous Nucleation of Hen‐Egg‐White Lysozyme—Molecular Approach

Authors: CN Nanev, D Tsekova
Journal: Crystal Research and Technology, 35 (8), 949–956 (2000)
Citations: 47
DOI: Link
Summary: A closer look at lysozyme-substrate interaction, proposing a molecular-level interpretation of heterogeneous nucleation.

📌 10. Protein Crystal Nucleation: Recent Notions

Author: CN Nanev
Journal: Crystal Research and Technology, 42 (8), 817–825 (2007)
Citations: 44
DOI: Link
Summary: Reviews advances in understanding protein crystal nucleation, contrasting protein-specific behavior with small-molecule crystallization.

Conclusion

Prof. Christo N. Nanev is an outstanding candidate for the Best Researcher Award. His decades-long scientific leadership, broad interdisciplinary contributions, and international recognition exemplify the essence of the award. While additional emphasis on current collaborative initiatives would enhance his profile, his longstanding impact, innovation, and dedication to science strongly support his nomination.

Qibin Liao | Immunology | Best Researcher Award

Published on 07/04/202507/04/2025 by Molecular Biologist

Dr. Qibin Liao | Immunology | Best Researcher Award

Assistant Researcher, at Shenzhen Third People’s Hospital, China.

Dr. Qibin Liao (b. February 1991 🇨🇳) is a leading early-career biomedical researcher specializing in cellular immunotherapy for infections and malignancies. Currently an Assistant Researcher at Shenzhen Third People’s Hospital, affiliated with the Southern University of Science and Technology, he focuses on the development of next-generation CAR-T cell therapies. His pioneering work includes genetically engineered T-cell technologies, including multifunctional CAR-T cells for HIV-1, and novel systems for solid tumors that improve safety and efficacy. Dr. Liao’s contributions have been widely recognized in high-impact journals such as EMBO Molecular Medicine, Biomedicines, and Cell Discovery. 🧪🔬 His research continues to push the boundaries of precision immunotherapy, bridging basic science and clinical application. He has also been awarded substantial national-level research funding and plays critical roles in multiple R&D programs. Through innovative designs and clinical translation, he is reshaping the future of personalized medicine and cancer treatment. 🌍💉

Professional Profile

🎓 Education

Dr. Qibin Liao began his academic journey at Southern Medical University where he earned a Bachelor of Medicine in Preventive Medicine (2010–2015). His strong foundation in public health and disease prevention laid the groundwork for his later focus on translational immunotherapy. 🚑🧠 He further advanced his training by pursuing a Ph.D. in Medical Systems Biology at Fudan University (2015–2021), one of China’s top-tier research institutions. Here, he honed his expertise in systems-level analysis and experimental techniques related to T-cell engineering and immunological signaling. His doctoral research contributed to the development of hypoxia-inducible CAR-T systems—a novel approach to improve safety and specificity in cancer therapy. 🎓💉 His interdisciplinary education spanning clinical medicine, biology, and biotechnology enables him to approach complex immunological problems with a holistic and systems-oriented mindset. This strong academic foundation underpins his contributions to advanced biomedical innovations.

💼 Professional Experience

Since October 2021, Dr. Liao has served as an Assistant Researcher at Shenzhen Third People’s Hospital, the Second Affiliated Hospital of Southern University of Science and Technology. 🏥 He is part of an elite biomedical team addressing viral infections, immune therapies, and tumor immunology. His role includes designing synthetic CAR-T constructs, leading clinical translational research, and supervising junior researchers in immunotherapy development. 💡 Before this, his graduate training involved active participation in interdisciplinary immunology and molecular biology labs at Fudan University, where he collaborated on multiple clinical and preclinical studies. His career is marked by a strategic blend of basic science and applied therapeutic innovation. Dr. Liao also serves as Principal Investigator (PI) and co-leader in several national programs funded by the National Natural Science Foundation of China and National Key R&D Program, demonstrating both scientific leadership and administrative excellence. 🧪📊

🔬 Research Interests

Dr. Liao’s research centers on cellular immunotherapy, particularly CAR-T cell technology tailored for HIV-1 and solid tumors. 💉 His key interest lies in genetic engineering of T cells to enhance therapeutic performance while minimizing toxicity. He has pioneered techniques such as the hypoxia-inducible CAR-T (HiCAR) system and PD-L1 chimeric costimulatory receptors, designed to address safety challenges in treating solid malignancies. 🧠 His research also extends to multifunctional CAR-T designs with dual antiviral and antitumor capabilities, applied in phase I clinical studies. Dr. Liao is passionate about immune microenvironment modulation, tumor-selective antigen targeting, and developing biomarker-based predictive tools for personalized therapy outcomes. 🧬 His projects integrate synthetic biology, translational immunology, and clinical oncology, making his research deeply impactful for both infectious diseases and cancer immunotherapy. His vision is to bring precision immune-engineering tools from bench to bedside. 🧑‍🔬🦠

🏆 Awards

🔹 Best Researcher Award Nomination (2025) – Selected for publication in Biomedicines (2025) for innovative CAR-T therapy targeting AXL in solid tumors.
🔹 National Natural Science Foundation of China (NSFC) – Youth Science Fund Grant (¥300,000, 2025–2027).
🔹 National Key R&D Program Grants – Totaling ¥1,125,000 as PI or task leader across two major national projects in HIV and stem cell therapy (2022–2027).
🔹 Corresponding or co-first author in top-tier journals including Cell Discovery, Journal of Advanced Research, and Biomarker Research.
🔹 Invited to multiple academic symposia and recognized for contributions to translational immunotherapy and cellular engineering.
These accolades reflect his innovative thinking, scientific rigor, and clinical impact. 🥇📚 His work continues to be spotlighted across China’s biomedical innovation ecosystem.

📚 Top Noted Publications

Dr. Liao has authored/co-authored several impactful publications. Highlights:

1. Novel mRNA-Engineered Fully Human CAR-T Cells Targeting AXL in Solid Tumors

Journal: Biomedicines
Year: 2025
Cited by: 4
Summary:

Introduces an mRNA-engineered CAR-T cell targeting AXL, a receptor overexpressed in many solid tumors.
Uses a fully human scFv to reduce immunogenicity.
Demonstrates promising anti-tumor effects in preclinical solid tumor models, with transient CAR expression for improved safety.

2. Safe CAR-T: Shedding Light on CAR-Related T-cell Malignancies

Journal: EMBO Molecular Medicine
Year: 2025
Cited by: 7
Summary:

Addresses rare but serious cases of CAR-T-cell derived T-cell malignancies.
Explores the integration of CAR constructs into oncogenes as a potential risk.
Discusses safer vector systems and genomic insertion site monitoring.

3. Efficacy and Safety of M10 CAR-T Cells in HIV-1-Infected Patients

Journal: Cell Discovery
Year: 2024
Cited by: 18
Summary:

Describes M10 CAR-T cells engineered to target HIV-1-infected cells.
First-in-human data showed viral suppression and CD4+ T-cell recovery.
Provides early evidence for CAR-T application in chronic viral infections.

4. Biomarkers for Predicting CAR-T Efficacy and Detection Methods

Journal: iLABMED
Year: 2024
Cited by: 6
Summary:

Reviews current predictive biomarkers (e.g., tumor burden, cytokine profiles, T-cell exhaustion markers).
Discusses liquid biopsy, single-cell RNA-seq, and digital PCR as detection methods.
Emphasizes personalized CAR-T strategies using biomarker profiling.

5. Mouse Model for Evaluating CAR-T On-Target Toxicity

Journal: Journal of Advanced Research
Year: 2023
Cited by: 11
Summary:

Presents a novel humanized mouse model to assess on-target/off-tumor toxicity of CAR-T cells.
Demonstrates the importance of tissue-specific antigen expression in predicting adverse effects.
Tool for preclinical safety validation.

6. Hypoxia-Inducible CAR-T Cells (HiTA System)

Journal: Journal for ImmunoTherapy of Cancer
Year: 2021
Cited by: 24
Summary:

Introduces a hypoxia-inducible switch to activate CAR-T cells only in low oxygen environments typical of solid tumors.
Reduces systemic toxicity while maintaining anti-tumor efficacy.
Demonstrates improved safety in vivo with retained tumor-killing activity.

7. PD-L1 Chimeric Receptor Improves Efficacy in Solid Tumors

Journal: Biomarker Research
Year: 2020
Cited by: 27
Summary:

Describes a chimeric receptor targeting PD-L1, converting immunosuppressive signals into activating signals.
Enhances CAR-T function in immunosuppressive microenvironments.
Synergistic potential with checkpoint inhibitors.

8. HiCAR for Selective Tumor Killing

Journal: Biomarker Research
Year: 2020
Cited by: 21
Summary:

Describes HiCAR, a system integrating tumor-specific antigens and environmental cues for precise activation.
Uses dual-input logic for increased specificity and reduced toxicity.
Aimed at improving solid tumor selectivity of CAR-T therapies.

Conclusion

Dr. Qibin Liao is highly suitable for the Best Researcher Award. His work on CAR-T innovations for both cancer and HIV is pioneering, impactful, and clinically relevant. The blend of scientific innovation, clinical translation, and strong funding/publication record positions him among the top emerging researchers in biomedical science in China.

ALI MEKKI | Microbiology | Excellence in Research

Published on 07/04/202507/04/2025 by Molecular Biologist

Prof. Dr. ALI MEKKI | Microbiology | Excellence in Research

Full Professor/Senior Researcher,at Sfax University, Tunisia.

Dr. Ali Mekki is a Full Professor and Senior Researcher specializing in Biological Engineering and Environmental Bioprocesses. 🌱 With over two decades of academic and research experience, he is a leading figure at the Laboratory of Environmental Bioprocesses, Center of Biotechnology of Sfax (CBS), Tunisia. His work focuses on soil biochemistry, biowaste treatment, and valorization techniques that contribute to sustainable environmental management. 🌍 Dr. Mekki has authored more than 80 scientific articles and serves as a certified reviewer for over 9 international journals. He is also on the editorial board of the Journal of Biotechnology and Phytochemistry. A respected mentor and innovator, Dr. Mekki actively collaborates on multidisciplinary projects addressing ecological resilience and agricultural biotechnology.

Professional Profile